FDA Adverse Event
Death
Summary report: N
SYNVISC PFS 8MG/ML (3X2ML)
MDR report key: 19712239
·
Received July 9, 2024
Report
- Report Number
- MW5157130
- Event Type
- Death
- Date Received
- July 9, 2024
- Report Date
- July 5, 2024
- Manufacturer
- GENZYME CORPORATION
- Product Code
- MOZ
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- US
- Reporter Occupation
- UNKNOWN
- Health Professional
- *
Narratives
Description of Event or Problem · 0
PT IS DECEASED. THE CAUSE OF DEATH WAS NOT PROVIDED BY THE REPORTER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2385712 | SYNVISC PFS 8MG/ML (3X2ML) | ACID, HYALURONIC, INTRAARTICULAR | MOZ | GENZYME CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR | Male | Death |